Nina Capital is a Barcelona-based venture capital firm founded in 2019, specializing in investments at the intersection of healthcare and technology. The firm employs a need-driven, value-based approach to healthcare innovation, informed by the Stanford Biodesign methodology. Nina Capital invests broadly across Europe with a collaborative approach in working and interacting with other players in the industry. Their goal is to help thoughtful and committed teams bridge the chasm from founding to series A capital and access global markets.
Below, we've gathered the investment thesis of Nina Capital to help you qualify how well they align with your fundraising goals.You can access their full contact details and your calculated match score on Hopohopo.io.
Nina Capital focuses on investing in pre-seed and seed-stage companies that are transforming healthcare through information technology.The firm seeks founders who combine a deep understanding of the complex healthcare ecosystem with engineering innovation, advanced data science, and IT-enabled products and services.
Invest in
Baltics
Nordics
Western Europe
Southern Europe
Central Eastern Europe
North America
2 / 3
Middle East
2 / 16
Customer types
B2B2C
Consumers
Governments
Large enterprises
Small and medium enterprises
Product type
Hardware
Software
Software-enabled hardware
Industries / verticals
BioTech
HealthTech / MedTech
Life Science
Investment details
Investment role
Lead and follow
Stages
Pre-seed, Seed, Series A
First ticket size
€200,000 - €1,500,000
Related contacts
Principal, Head of Investments
Sebastian Anastassiou
Partner
Ken Douglas
Chief Innovation Officer
Jorge Garcia
Direttore Area Privati Humanitas | Private Healthcare Business Unit Director